MEET OUR EXPERTS AT SOT-toxexpo 2021
Talk to the pre-clinical development experts and TOX-ADME specialists
Our pre-clinical teams at Evotec and Cyprotex are experts in toxicology & pathology, drug metabolism & pharmacokinetics, drug transporters and pre-clinical and clinical bioanalysis. We offer a full range of in vitro and in vivo GLP and non-GLP pre-clinical evaluation studies to thoroughly assess the safety profile of small and large molecules for a broad range of therapeutic areas.
Get in touch to arrange a meeting with one of our scientific specialists!
DON'T MISS OUR EXHIBITOR HOSTED SESSIONS
Add them to your SOT schedule!
|
It's All in the Genes! Using Transcriptomics Combined with Cellular Imaging to Derisk DILI In this presentation, delegates will learn about the latest methods to assess in vitro cellular toxicology, including a guide to utilising transcriptomics and 2D and 3D cellular imaging to improve DILI prediction, and provide a better mechanistic understanding of toxicological pathways. |
SEND: The Benefits Behind The Scenes SEND, an implementation of the CDISC Study Data Tabulation Model (SDTM), provides a framework for the standardized, electronic representation of individual animal study data. Even if SEND is intended to increase the effectiveness and efficiency of data review for regulatory submissions, this framework poses several other advantages that go beyond regulatory requirements. This session will take you through real life experiences of these benefits for toxicology and safety pharmacology studies. |
| March 16th @ 3-4pm EDT | March 23rd @ 9-10am EDT |
| Presented by | |
 |
Christopher Strock |
 |
Marco Pergher Senior Manager, Pharmacometrics Evotec |
 |
Dario Salerno Manager In Vivo Safety, Safety Assessment, Evotec |
||
 |
Moderator Michela Pecoraro VP, Safety Assessment, Evotec |
CYPROTEX pOSTER PRESENTATIONS
| Assessing the Differential Sensitivities of a Microelectrode Array Assay and a Neurite Outgrowth Assay for Detecting CNS Liabilities Using a Set of Neurotoxic and Seizurogenic Compounds | Transcriptomic Profiling of in vitro 2D and 3D Models to Predict Drug Induced Liver Injury (DILI) | A combined in vitro approach for the dual detection of functional and structural cardiotoxicity |
| Presenter: Christopher Strock | Presenter: Paul Walker | Presenter: Stephanie Ryder |
|
March 22 @11:15am – 1pm EDT |
March 25 @1pm-2:45pm EDT poster number 3179/P162 |
March 25 @1pm-2:45pm EDT |
A copy of our presentations can be sent after SOT!
nAVIGATING THE DRUG DISCOVERY TO DEVELOPMENT CONTINUUM
Sign up to our new webinar series to learn how Evotec's fully integrated discovery and development continuum enables both the invention and selection of the highest quality drug candidates.
In addition to reducing timelines and overall costs, this approach has led to increased success rates from pre-development candidate nomination to clinical development with the potential to deliver much needed new medicines to patients together with significantly improved ROI.
did you miss our webinars? watch them now!
| New Approaches in Toxicology | Cyprotex webinar series Presented by Cyprotex, Takeda, ApconiX and Uni Liverpool |
A Focus on Drug Transporters | Cyprotex webinar series |
| Abuse Liability Assessment of new drugs from candidate selection to New Drug Application Presented by Dr Mary Jeanne Kallman |
Abuse Liability Assessment of new drugs: core preclinical studies to address regulatory requirements Presented by Michela Tessari |
| Cell Therapy and Preclinical Development Presented by Nicoletta Garbati |
Cell and Gene Therapy for Cancer: From Concept to Clinic Presented by Prof. Massimo Dominici |
| Novel Gene Therapies for Rare Diseases: Evotec and Takeda Join Forces Presented by Hanspeter Rottensteiner, Evotec, and Vivian Choi, Takeda |
High-sensitivity immunoassays for biomarkers of Huntington’s disease Sponsored by Millipore Sigma and presented by Chantal Bazenet and Elena Vicentini |
Looking forward to meeting you virtually at SOT!
